This makes PSMA an excellent biological target for diagnosis and treatment of prostate cancer.30 A high number of PSMA-targeting radioligands are known, including the diagnostic gold standard [68Ga]Ga-PSMA-11 and the therapeutic counterpart [177Lu]Lu-PSMA-617.31 Here, FOLH1 is linked to prostate carcinoma.